Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Contraception. 2019 Jun 10;100(4):283–287. doi: 10.1016/j.contraception.2019.06.002

Table 1.

Baseline Characteristics of Subjects in the Control arm (COCs) or Ritonavir Arm (COCs+Ritonavir)

COCs COCs+Ritonavir
Subjects N 10 5
Hispanic N (%) 8 (80) 5 (100)
Age (years)a 34.5 (30,42) 38 (29,41)
Weight (kg)a 72.3 (58.5,86.6) 58.5 (57.6,70.8)
BMI (kg/m2)a 28.6 (24.8,36.1) 26.4 (24.0,29.5)
Paritya 2 (1,4) 3 (3,4)
Smoking N (%) 1 (10) 0 (0)
History of opportunistic infection none none
CD4 (cells/mm3)a 830 (571,1082) 811 (229,1047)
Baseline progesterone (ng/mL)a 8.6 (4.5,11.6) 6.4 (5.9,12.2)
Creatinine (mg/dL)a 0.68 (0.55,0.90) 0.71 (0.51,0.99)
a

Data are presented as median (min, max).